Detalhe da pesquisa
1.
Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP).
Medicina (Kaunas)
; 60(3)2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38541156
2.
CHRONIC MEDICAL CONDITIONS IN CROATIAN WAR VETERANS COMPARED TO THE GENERAL POPULATION: 25 YEARS AFTER THE WAR.
Acta Clin Croat
; 62(1): 3-10, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38304376
3.
Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis.
Ann Hematol
; 99(12): 2779-2785, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862283
4.
Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis.
Ann Hematol
; 103(6): 2157-2159, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652241
5.
The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera.
Am J Hematol
; 99(5): 989-992, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38391037
6.
The impact of statins on the intensity of phlebotomies in polycythemia vera.
Ann Hematol
; 99(4): 911-912, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025841
7.
Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era-A Study of KroHem, the Croatian Group for Hematologic Diseases.
Biomedicines
; 12(2)2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397933
8.
Evaluation of Absolute Neutrophil, Lymphocyte and Platelet Count and Their Ratios as Predictors of Thrombotic Risk in Patients with Prefibrotic and Overt Myelofibrosis.
Life (Basel)
; 14(4)2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672793
9.
High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia.
Wien Klin Wochenschr
; 134(11-12): 483-486, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35391561
10.
Hematocrit to hemoglobin ratio as a prognostic marker in polycythemia vera.
Wien Klin Wochenschr
; 134(3-4): 110-117, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34738212
11.
Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis.
Wien Klin Wochenschr
; 134(3-4): 97-103, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33464403
12.
Beneficial effect of ACE inhibitors on kidney function in polycythemia vera.
Wien Klin Wochenschr
; 133(15-16): 808-815, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555393
13.
C reactive protein to albumin ratio as prognostic marker in primary and secondary myelofibrosis.
Leuk Lymphoma
; 61(12): 2969-2974, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654566
14.
Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia.
Leuk Lymphoma
; 65(5): 688-691, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38248137
15.
Chronic Kidney Disease has a Higher Prevalence in Polycythemia Vera than in Secondary Polycythemia, a Matched Case-Control Analysis.
Indian J Hematol Blood Transfus
; 39(4): 708-709, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37786828
16.
High plateletcrit may be associated with thrombotic risk in polycythemia vera.
Int J Lab Hematol
; 45(5): 799-801, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37050866
17.
Palpable spleen size is differently prognostic in primary and secondary myelofibrosis.
Leuk Lymphoma
; 64(4): 893-896, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799562
18.
Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms.
Thromb Res
; 231: 141-143, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964024
19.
Serum osmolarity in polycythemia vera and its clinical associations.
Int J Lab Hematol
; 44(5): e191-e194, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365945
20.
Estimating plasma volume using the Strauss-derived formula may improve prognostication in polycythemia vera.
Int J Lab Hematol
; 44(2): e69-e71, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34581007